Role of cytokines in autologous bone marrow transplantation

W. P. Peters, M. Ross, J. Vredenburgh, A. Hussein, B. Meisenberg, C. Gilbert, W. P. Petros, J. Kurtzberg

Research output: Contribution to journalArticle

Abstract

High-dose chemotherapy with autologous bone marrow support has been increasingly used in the treatment of malignant disease. The use of hematopoietic colony-stimulating factors (CSF), particularly when coupled with the use of CSF-primed peripheral blood progenitor cells, has enabled a substantial reduction in the duration of severe leukopenia and in the morbidity associated with bone marrow transplantation. Furthermore, their use has reduced resource utilization and hospital charges and has also permitted the performance of autologous bone marrow transplantation support largely on an outpatient basis.

Original languageEnglish (US)
Pages (from-to)737-747
Number of pages11
JournalHematology/Oncology Clinics of North America
Volume7
Issue number3
StatePublished - 1993
Externally publishedYes

Fingerprint

Colony-Stimulating Factors
Autologous Transplantation
Bone Marrow Transplantation
Cytokines
Hospital Charges
Leukopenia
Blood Cells
Outpatients
Stem Cells
Bone Marrow
Morbidity
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Peters, W. P., Ross, M., Vredenburgh, J., Hussein, A., Meisenberg, B., Gilbert, C., ... Kurtzberg, J. (1993). Role of cytokines in autologous bone marrow transplantation. Hematology/Oncology Clinics of North America, 7(3), 737-747.

Role of cytokines in autologous bone marrow transplantation. / Peters, W. P.; Ross, M.; Vredenburgh, J.; Hussein, A.; Meisenberg, B.; Gilbert, C.; Petros, W. P.; Kurtzberg, J.

In: Hematology/Oncology Clinics of North America, Vol. 7, No. 3, 1993, p. 737-747.

Research output: Contribution to journalArticle

Peters, WP, Ross, M, Vredenburgh, J, Hussein, A, Meisenberg, B, Gilbert, C, Petros, WP & Kurtzberg, J 1993, 'Role of cytokines in autologous bone marrow transplantation', Hematology/Oncology Clinics of North America, vol. 7, no. 3, pp. 737-747.
Peters WP, Ross M, Vredenburgh J, Hussein A, Meisenberg B, Gilbert C et al. Role of cytokines in autologous bone marrow transplantation. Hematology/Oncology Clinics of North America. 1993;7(3):737-747.
Peters, W. P. ; Ross, M. ; Vredenburgh, J. ; Hussein, A. ; Meisenberg, B. ; Gilbert, C. ; Petros, W. P. ; Kurtzberg, J. / Role of cytokines in autologous bone marrow transplantation. In: Hematology/Oncology Clinics of North America. 1993 ; Vol. 7, No. 3. pp. 737-747.
@article{0e0ede562f3f4476865992ac46f24a59,
title = "Role of cytokines in autologous bone marrow transplantation",
abstract = "High-dose chemotherapy with autologous bone marrow support has been increasingly used in the treatment of malignant disease. The use of hematopoietic colony-stimulating factors (CSF), particularly when coupled with the use of CSF-primed peripheral blood progenitor cells, has enabled a substantial reduction in the duration of severe leukopenia and in the morbidity associated with bone marrow transplantation. Furthermore, their use has reduced resource utilization and hospital charges and has also permitted the performance of autologous bone marrow transplantation support largely on an outpatient basis.",
author = "Peters, {W. P.} and M. Ross and J. Vredenburgh and A. Hussein and B. Meisenberg and C. Gilbert and Petros, {W. P.} and J. Kurtzberg",
year = "1993",
language = "English (US)",
volume = "7",
pages = "737--747",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Role of cytokines in autologous bone marrow transplantation

AU - Peters, W. P.

AU - Ross, M.

AU - Vredenburgh, J.

AU - Hussein, A.

AU - Meisenberg, B.

AU - Gilbert, C.

AU - Petros, W. P.

AU - Kurtzberg, J.

PY - 1993

Y1 - 1993

N2 - High-dose chemotherapy with autologous bone marrow support has been increasingly used in the treatment of malignant disease. The use of hematopoietic colony-stimulating factors (CSF), particularly when coupled with the use of CSF-primed peripheral blood progenitor cells, has enabled a substantial reduction in the duration of severe leukopenia and in the morbidity associated with bone marrow transplantation. Furthermore, their use has reduced resource utilization and hospital charges and has also permitted the performance of autologous bone marrow transplantation support largely on an outpatient basis.

AB - High-dose chemotherapy with autologous bone marrow support has been increasingly used in the treatment of malignant disease. The use of hematopoietic colony-stimulating factors (CSF), particularly when coupled with the use of CSF-primed peripheral blood progenitor cells, has enabled a substantial reduction in the duration of severe leukopenia and in the morbidity associated with bone marrow transplantation. Furthermore, their use has reduced resource utilization and hospital charges and has also permitted the performance of autologous bone marrow transplantation support largely on an outpatient basis.

UR - http://www.scopus.com/inward/record.url?scp=0027207228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027207228&partnerID=8YFLogxK

M3 - Article

C2 - 8344888

AN - SCOPUS:0027207228

VL - 7

SP - 737

EP - 747

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 3

ER -